Agios Pharmaceuticals (AGIO) Profit After Tax (2012 - 2026)
Agios Pharmaceuticals (AGIO) posted Profit After Tax of -$99.1 million for Q1 2026, up 8.26% on a QoQ basis from -$108.0 million in Q4 2025, and down 11.0% year-over-year from -$111.4 million in Q1 2025.
Agios Pharmaceuticals (AGIO) Profit After Tax (2012 - 2026) Analysis & Trends
Agios Pharmaceuticals' Profit After Tax history runs 15 years deep, the most recent figure standing at -$99.1 million for Q1 2026.
- Quarterly Profit After Tax fell 11.0% year-over-year to -$99.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$422.6 million (down 163.46% YoY) and the FY2025 annual result came in at -$412.8 million, down 161.27% from the prior year.
- Profit After Tax was -$99.1 million for Q1 2026 at Agios Pharmaceuticals, up from -$108.0 million in the prior quarter.
- Across five years, Profit After Tax topped out at $947.9 million in Q3 2024 and bottomed at -$112.0 million in Q2 2025.
- A 5-year average of -$24.8 million and a median of -$91.8 million in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax slumped 362.66% — and 2024, when it jumped 1137.97%.
- Agios Pharmaceuticals' Profit After Tax stood at $36.5 million in 2022, then slumped by 362.66% to -$95.9 million in 2023, then slipped by 0.61% to -$96.5 million in 2024, then fell by 11.93% to -$108.0 million in 2025, then gained by 8.26% to -$99.1 million in 2026.
- Business Quant data shows AGIO's Profit After Tax at -$99.1 million in Q1 2026, -$108.0 million in Q4 2025, and -$103.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | -99.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99.11 Mn |
| Dec 31, 2025 | -108.04 Mn |
| Sep 30, 2025 | -103.43 Mn |
| Jun 30, 2025 | -112.02 Mn |
| Mar 31, 2025 | -89.29 Mn |
| Dec 31, 2024 | -96.52 Mn |
| Sep 30, 2024 | 947.92 Mn |
| Jun 30, 2024 | -96.12 Mn |
| Mar 31, 2024 | -81.55 Mn |
| Dec 31, 2023 | -95.94 Mn |
| Sep 30, 2023 | -91.32 Mn |
| Jun 30, 2023 | -83.81 Mn |
| Mar 31, 2023 | -81.02 Mn |
| Dec 31, 2022 | 36.53 Mn |
| Sep 30, 2022 | -81.75 Mn |
| Jun 30, 2022 | -91.81 Mn |
| Mar 31, 2022 | -94.77 Mn |
| Dec 31, 2021 | -98.58 Mn |
| Sep 30, 2021 | -84.26 Mn |
| Jun 30, 2021 | -86.22 Mn |